General discussion, page-168

First 168 Last

Share
Profile

Follow
UnclePanda

2,454 Posts.

68

18/04/20

21:44

Post #: 44121445
Share

Originally posted by Exalted: ↑

We'll find out within the next two weeks mate. Where'd you get the 2M figure from?

But also remember that Sud's Cannvalate oppie exercising can counter the expenses of the trials to last EOY even if there are increased losses.
Total that he can exercise, all expire EOY this year is ~$10M. At price points now currently from 4c-14c. So far Sud has exercised his 2c and 3c packages ASAP when he recieved them for milestones.

No doubt when we get a SP pump though off the back of hopefully trial results they will likely raise again.
The timing of this is crucial though, considering IHLOB expires Sep this year. If the team can get IHLOB in the money and get them all exercised they will get $10M in the bank.

Then perhaps they may not do a raise if IHLOB gets ITM and Sud exercises all Cannvalate oppies because we'd get +$20M in the bank, but that is 50/50 especially if they want to fasttrack even more trials or move to Phase 3 for OSA etc.

The way the board has set this up is especially risky, considering most of the cash inflow we are supposed to recieve will come from options exercising. $20M total, I think either 10 or 10.5M for IHLOB and vice-versa for Cannvalate options. All expiring sometime this year.

That either indicates absolute confidence or stupidity as we will find out soon.

Expand

where did the $2M figure come from? gut feeling. last quarter they said they projected $1.45M cash burn this quarter and they have signed a lot more deals which cost money for new products, paid for patents and FDA consulting advice etc, and have to pay the medical board.

IMO, they will miss the dead line for Suds 4 cent options. not because they didn't try, but because there's so much to do with patent applications and other regulatory work. I think they will announce an amended incentive structure for Suds options that share holders will have to vote on cause it's not fair to miss out on some cheap oppies for just slightly missing deadlines and they aren't doing the AXIM product anymore.

IHL Price at posting: 5.9¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply